Assessing the Quality of Life Using the Health Utilities Index Questionnaire in Children With Severe Persistent Asthma During the Treatment With Omalizumab

Pediatric pharmacology
doi 10.15690/pf.v14i5.1783
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Paediatrician Publishers LLC

Related search

Prs105 - The Assessment the Health Utilities Index in Children With Severe Persistent Uncontrolled Asthma, Receiving Omalizumab

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prs106 - The Assessment the Quality of Life in Children With Severe Persistent Uncontrolled Asthma, Receiving Omalizumab, by the Health Utilities Index and Standardised Paediatric Asthma Quality of Life Questionnaire(according to the Pediatric Registry)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Lengthening Omalizumab Dosing Interval in Treatment of Moderate to Severe Persistent Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?

European Clinical Respiratory Journal
2017English

First Experience With Omalizumab in a Child With Severe Persistent Asthma in Turkey: Case Report

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2010English

The Long-Term Omalizumab Therapy in Children With Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry

Pediatric pharmacology
2018English

P170 Long-Term Effectiveness of Omalizumab in Patients With Severe Persistent Allergic (IgE-mediated) Asthma: UK Centre Real-Life Experience

Thorax
PulmonaryRespiratory Medicine
2013English

Assessment of Quality of Life in Asthmatic Children and Their Caregivers After Treatment With Omalizumab

Pediatrics & Therapeutics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy